Eddy Pharmaceutical\'s announcement on holding a results briefing for the third quarter of 2024
Eddy Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. Foreign Investment Management System (revised in October 2024)
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Asset Impairment Preparation for the First Three Quarters of 2024
Eddy Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. Fund Raising Management Measures (Revised in October 2024)
Eddy Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. External Guarantee Management System (revised in October 2024)
Eddy Pharmaceuticals: Announcement of Resolutions of the 26th Meeting of the 2nd Board of Supervisors of Eddy Pharmaceuticals
Eddy Pharmaceutical: Constitution of Jiangsu Eddy Pharmaceutical Co., Ltd. (Revised in October 2024)
Eddy Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. regulates the financial exchange system with related parties (revised in October 2024)
Eddy Pharmaceuticals: Announcement of Resolutions of the 27th Meeting of the 2nd Board of Directors of Eddy Pharmaceuticals
Adi Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. Related Transactions Implementation Rules (Revised in October 2024)
Jiangsu Eddy Pharmaceutical Co., Ltd. Independent Director Work System (Revised in October 2024)
Jiangsu Eddy Pharmaceutical Co., Ltd. External Guarantee Management System (revised in October 2024)
Rules of procedure for the shareholders\' meeting of Jiangsu Eddy Pharmaceutical Co., Ltd. (revised in October 2024)
Rules of Procedure for the Supervisory Board of Jiangsu Eddy Pharmaceutical Co., Ltd. (Revised in October 2024)
Jiangsu Eddy Pharmaceutical Co., Ltd. Fund Raising Management Measures (Revised in October 2024)
Eddy Pharmaceuticals Announces Renewal of the Accounting Firm
Announcement of Resolutions of the 26th Meeting of the 2nd Supervisory Board of Eddy Pharmaceuticals
Announcement of Resolutions of the 27th Meeting of the 2nd Board of Directors of Eddy Pharmaceuticals
Eddy Pharmaceuticals: Eddy Pharmaceuticals Voluntary Disclosure Notice on Approval of the Marketing Application for New Indications of Enomie Tablets
Eddy Pharmaceuticals: Eddy Pharmaceuticals Progress Notice on Major Asset Restructurings
No Data